Conference
Secukinumab provides greater 52-week sustained relief from dermatology-related quality of life impact on clothing choice and sexual function than ustekinumab
Authors
Blauvelt A; Mehlis S; Vanaclocha F; Vender R; Zhao Y; Gilloteau I; Williams N; Guana A; Tyring S
Volume
76
Pagination
pp. AB230-AB230
Publisher
MOSBY-ELSEVIER
Publication Date
June 1, 2017
Name of conference
Annual Meeting of the American-Academy-of-Dermatology
Conference place
Orlando, FL
Conference start date
March 3, 2017
Conference end date
March 7, 2017
Conference proceedings
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Issue
6
ISSN
0190-9622